Академический Документы
Профессиональный Документы
Культура Документы
Log out
Overview
Library
Qbank
Analysis
Shop
Account
/ 422
A 17-year-old boy comes to the physician for a follow-up examination. Two months ago,
he suffered a spinal fracture after a fall from the roof. He feels well. His father has multiple
endocrine neoplasia type 1. Vital signs are within normal limits. Examination shows no
abnormalities. Laboratory studies show:
Sarcoidosis
b
Familial hypocalciuric hypercalcemia (FHH) would result in elevated calcium and mildly
elevated ALP levels. However, phosphate levels would be either normal or decreased.
c
ImmobilizationS
Prolonged immobilization (e.g., following a vertebral fracture) can lead to increased bone
demineralization with mild hypercalcemia, hyperphosphatemia, and increased alkaline
phosphatase.
d
Parathyroid adenoma
The family history of multiple endocrine neoplasia might suggest a diagnosis of parathyroid
adenoma, which would result in hypercalcemia and mildly increased ALP levels (as a result
of primary hyperparathyroidism). However, patients with parathyroid adenoma would have
hypophosphatemia because PTH receptor activation in the proximal convoluted tubule
decreases renal phosphate reabsorption.
e
Pseudohypercalcemia
Pseudohypercalcemia occurs in patients with increased serum protein concentration (e.g., due
to hyperalbuminemia in dehydrated patients or due to paraproteinemia in patients with
multiple myeloma) because approximately half of all serum calcium is bound to serum
proteins. This patient, however, has normal albumin and serum total protein levels.
f
Paraneoplastic syndrome
Paraneoplastic production of the PTH-related peptide (PTHrP) by tumors (at this patient's
age, e.g., neuroblastoma, renal tumors, and leukemia) can result in hypercalcemia and mildly
increased ALP levels. Phosphate levels, however, would be decreased because PTH receptor
activation in the proximal convoluted tubule decreases renal phosphate reabsorption. This
patient also lacks any clinical feature that would suggest an underlying malignancy (e.g.,
weight loss, fatigue, bone pain, abdominal pain, hematuria).
© 2019 AMBOSS | Terms and Conditions | Privacy | Legal Notice | Get Support & Contact
Us Ideas & Feedback